Wakefield Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Wakefield Asset Management's PFE Position: Q2 2025 in Review
Wakefield Asset Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 15,328 shares — an estimated $388K sold.
Wakefield Asset Management first reported a position in PFE in Q3 2018 and held it in 13 quarters. The position peaked at $2.29M in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Wakefield Asset Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Wakefield Asset Management sold 15,328 Pfizer shares in Q2 2025, an estimated $388K.
- Wakefield Asset Management first reported a position in Pfizer in Q3 2018 and held it in 13 quarters.
- Wakefield Asset Management's Pfizer position peaked at $2.29M in Q4 2021.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Wakefield Asset Management's 13F filing for Q2 2025, filed 5 Aug 2025.